What laboratory tests should be ordered to evaluate Parkinson disease?

Laboratory Testing for Parkinson's Disease

There are no routine laboratory tests that diagnose Parkinson's disease—the diagnosis remains primarily clinical—but specific lab tests should be ordered to exclude secondary causes, particularly Wilson's disease in younger patients. 1

Essential Laboratory Tests

Wilson's Disease Screening (Mandatory in Early-Onset Cases)

• When evaluating patients under age 50 with suspected Parkinson's disease, laboratory investigation for Wilson's disease is recommended as part of the core diagnostic workup. 1
• This typically includes serum ceruloplasmin, 24-hour urinary copper excretion, and potentially slit-lamp examination for Kayser-Fleischer rings. 1
• Wilson's disease is a treatable cause of parkinsonism that must not be missed, making this screening essential in the early-onset population. 1

Cerebrospinal Fluid Biomarkers (Research Stage)

• CSF α-synuclein and DJ-1 are being investigated as potential diagnostic markers but remain in the research phase and are not recommended for routine clinical use. 2
• These fluid biomarkers show promise for early detection but lack sufficient validation for standard clinical practice. 2

Serum Biomarkers (Investigational)

• Serum protein panels, autoantibody testing, and α-synuclein antibodies have demonstrated diagnostic capacity in research settings but are not yet clinically available or validated for routine diagnosis. 3, 2
• A 5-gene panel has shown high specificity and sensitivity in distinguishing early PD from healthy controls, but this remains investigational. 3
• Oxidative stress markers and mitochondrial function tests have been studied but are not standardized for clinical diagnosis. 4, 5

Clinical Context and Pitfalls

The Diagnosis Remains Clinical

• Laboratory tests serve only to exclude alternative diagnoses—they cannot confirm Parkinson's disease, which is diagnosed based on clinical features (bradykinesia plus rest tremor and/or rigidity). 6
• The absence of specific diagnostic lab tests often leads to diagnostic delays and unnecessary testing in early-onset cases. 1

When to Limit Laboratory Investigation

• If Parkinson's disease is suspected based on history and examination without additional findings concerning for secondary or genetic parkinsonism, laboratory investigation should be limited to Wilson's disease screening (in younger patients) and brain MRI. 1
• This focused approach expedites diagnosis and treatment initiation rather than pursuing extensive biomarker panels that lack clinical validation. 1

Genetic Testing Considerations

• Genetic testing (PARK1 through PARK11 genes) is not necessary for diagnosis but can be useful in early-onset cases to identify genetic etiologies and potential trial eligibility. 4, 1
• Genetic testing should be considered when there is family history, very early onset (under 40), or atypical features suggesting hereditary forms. 4, 1

Complementary Diagnostic Modalities (Not Laboratory Tests)

While not laboratory tests per se, the following are part of the diagnostic workup:

• Brain MRI without contrast is the preferred structural imaging to exclude alternative etiologies such as vascular disease, focal lesions, or atypical parkinsonian syndromes. 6
• I-123 ioflupane (DaT) SPECT is the most valuable functional test for differentiating true degenerative parkinsonism from mimics like essential tremor, though it cannot distinguish PD subtypes. 6
• Olfactory testing has very high sensitivity and specificity when combined with other detection methods, though it is not specific for PD alone. 3
• Cardiac MIBG scintigraphy can measure cardiac sympathetic denervation as a supportive finding. 2, 4